{
  "hypothesis": "h200",
  "title": "Brain Tumor Zero Hit Investigation",
  "status": "validated",
  "finding": "Brain tumor low precision is due to DRKG DRUG COVERAGE GAP, not model failure",
  "key_results": {
    "actual_precision": "1.8% (5/278 predictions), not 0%",
    "root_cause": "Brain-specific drugs NOT in DRKG embeddings",
    "temozolomide_status": "NOT IN DRKG (CHEBI:72564 missing)",
    "brain_drug_coverage": "0% (0/47 brain tumor drugs have embeddings)"
  },
  "evidence": {
    "gt_coverage": "51 brain tumor GT entries with 27 unique drugs",
    "drkg_coverage": "Only 1063 CHEBI compounds in DRKG, Temozolomide not among them",
    "prediction_analysis": "Model predicts generic chemo (Cisplatin, Fluorouracil) instead of brain-specific drugs"
  },
  "structural_issue": {
    "description": "DRKG lacks brain tumor-specific drugs like Temozolomide, so kNN cannot recommend them",
    "workaround_possible": false,
    "requires": "External drug-disease data or manual rule addition"
  },
  "recommendation": {
    "production": "Exclude brain tumors from confidence tiers OR add manual rules for known drugs",
    "future": "Consider integrating additional drug databases with better brain tumor coverage"
  }
}